Clinical Trial: Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Sponsor and Collaborators
Chronic Lymphocytic Leukemia Research Consortium
Celgene Corporation

Contact
Contact: Mary Carpenter, CRC
858-822-5635
[email protected]

Continue Reading

Contact: Danelle F James, MD
858-822-7894
[email protected]

Principal Investigator
Study Director: Thomas J Kipps, MD, PhD Director of the CLL Research Consortium and University of California San Diego

Principal Investigator: Danelle F James, MD, MAS CLL Research Consortium and University of California San Diego

ClinicalTrials.gov Identifier
NCT01199575